Carregant...
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Non-alcoholic steatohepatitis (NASH) is becoming a leading cause of cirrhosis with the burden of NASH-related complications projected to increase massively over the coming years. Several molecules with different mechanisms of action are currently in development to treat NASH, although reported effic...
Guardat en:
| Publicat a: | Gut |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497577/ https://ncbi.nlm.nih.gov/pubmed/32381514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319104 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|